Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Video Game Study Paves Path For Pivotal FDA Trial To Treat Pediatric ADHD

This article was originally published in The Gray Sheet

Executive Summary

A new video game treatment called Project: EVO being developed by Boston-based Akili Labs has crossed an important milestone with positive pilot study data for treating children with attention deficit hyperactivity disorder. The company is planning to launch a randomized, pivotal study to support FDA approval of a "prescription-strength video game" in the coming months.



Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts